Reaction profile

The FDA adverse-event record for lens luxation

Name: Lens luxation - FDA Animal Adverse Reaction
Creator: PlainBreed
License: https://open.fda.gov/license/

25 FDA reports name lens luxation, a lower-volume reaction in the CVM extract (VeDDRA 447). Plate stamps and neighbourhood peers follow.

#2074 of 2,481
by report volume (all reactions): 25
reports citing this reaction: 8.0%
death-coded share: Dog
most-affected species

Compiled by PlainBreed

Verify with FDA CVM →

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Lens luxation has 25 reports now versus 25 in that prior snapshot: 0 the same number of (0.0%).

Report change: +0
Death-coded reports: +0
Death-coded share: +0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Lens luxation changes

FDA AER · VeDDRA plate

Code 447 VOL-TRACE

VOL-TRACE · DEATH-PAR · LOWER-Q · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

VOL-TRACE 25 reports
DEATH-PAR 8.0%
LOWER-Q #2074/2481
PHOTO-FINISH Abnormal behaviour NOS
SPECIES-DOG Dog · 21
DRUG-LEAD Oclacitinib Malea… · 4
DESK-WIDE 18 breeds
BOOK-FULL 8/8 fields

Nearest volume peer: Abnormal behaviour NOS (±0 reports)

Instrument codes from this reaction’s FDA CVM adverse-event extract: volume band, death-coded share, corpus rank, photo-finish peer, lead species, lead drug, breed desk, and book completeness. Not a clinical diagnosis.

Lower-volume neighbourhood around Lens luxation

Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.

FDA AER report volume · neighbourhood around Lens luxation

Lens luxation: low death-coded share in the FDA AER plate

Signature read: 25 reports place Lens luxation in the lower third of FDA AER volume (#2074 of 2,481). Report volume is lower-third scale: 25 named reports in the openFDA extract. Death-coded share is lower-third: 2 of 25 reports (8.0% of named reports). Nearest volume peer: Abnormal behaviour NOS (±0 reports). Lead species Dog (21). Lead co-reported drug Oclacitinib Maleate (4).

Read these counts as reporting volume, not risk: per our methodology, Lead co-reported drug Oclacitinib Maleate appears in filings alongside this reaction; that is association, not causation. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 21

Cat 4

Breeds Most Affected

Chihuahua 4

Terrier (unspecified) 2

Crossbred Canine/dog 2

Domestic Shorthair 2

Terrier - Boston 2

Pug 1

Retriever - Labrador 1

Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 1

Beagle 1

Spaniel - Cocker American 1

Associated Drugs

Oclacitinib Maleate 4

Trilostane 3

Recombinant Human Insulin 2

Milbemycin Oxime + Spinosad 2

Spinosad 2

Maropitant Citrate 2

Bedinvetmab 2

Diphenhydramine 1

Etofenprox, Piperonyl Butoxide, N-Octyl Bicycloheptene Dicarboximide 1

Fluralaner Chew Tablets 1

Allergy Shot (Unknown) 1

Milbemycin Oxime 1

Imidacloprid; Permethrin; Pyriproxyfen 1

Robenacoxib 1

Orbifloxacin 1

Fluid Therapy (Unknown) 1

Prednisolone; Trimeprazine Tartrate 1

Dorzolamide Hcl 1

Insulin Injectable Vial 1

Miconazole + Polymyxin B + Prednisolone 1

What to do with this reaction

Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
Browse the full reaction directory to compare report counts across reaction types. All reactions

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Lens luxation (#2074 of 2,481 by report volume); death-coded 8.0%. PlainBreed reaction plate · report volume stamp 25 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →